News and press

For the latest on the data investigation following the 2024 Cyberattack, please visit synnoviscyberupdate.co.uk.

For all related media queries, please contact:
Telephone : +44 (0) 20 3077 0549
Email: synnovisqueries@fticonsulting.com

Filter by:

2nd September 2014

The fight against Sickle Cell Disease in Nigeria

Viapath’s Dr Yvonne Daniel has just returned from Nigeria where she has worked with Dr Baba Inusa of Guy’s and St Thomas’ Hospital, to progress the roll out of newborn Sickle Cell Disease screening.

13th August 2014

Calreticulin (CALR) Mutation Screen available

Complementing our full myeloproliferative disease (MPD) diagnostic service, we now offer the CALR mutation screen.

11th August 2014

Viapath contributes to pioneering gene sequencing project

We excited to be playing a key role in a revolutionary £300m government backed gene sequencing program.

16th July 2014

Delegates to Viapath Innovation Academy face the challenge of ‘keeping people healthy’

Successful event focuses on new science, new diagnostics and how applying existing knowledge in more integrated innovative ways can improve patient outcomes.

16th July 2014

Leading non-invasive prenatal test now available through Viapath

Viapath is proud to be the sole provider of the verifi® non-invasive prenatal test in the South East of England.

2nd July 2014

Vitamin D deficiency and its correction in children with sickle cell disease

Wykes C, Arasaretnam A, O’Driscoll S, Farnham L, Dees DC

1st July 2014

Viapath strengthens leadership team with new Chief Operating Officer

Viapath makes key addition to executive leadership team with the appointment of Dougie Dryburgh as COO.

26th June 2014

Professor Roy Sherwood on Carbohydrate deficient transferrin (CDT) as a marker of chronic excess alcohol intake

20% of hospital admissions are alcohol related, rising on weekends. CDT is elevated in the blood of heavy alcoholism and is slowly coming of age as the best marker of chronic excess alcohol intake.

10th June 2014

National newborn screening pilot expanded

The number of disorders newborn babies are tested for is set to increase thanks to successful pilot involving our Newborn Screening Laboratory.

6th May 2014

Adrenocortical adenomas with regression and myelolipomatous changes: urinary steroid profiling supports a distinctive benign neoplasm

Victoria Perna, Dorota Dworakowska, Klaus-Martin Schulte, Simon Aylwin, Fatima Al-Hashimi, Salvador J. Diaz-Cano

Last updated: 23/09/2022

Search form

News and press

eMail alerts and news

Site details

Search form

News and press

Share this page

eMail alerts and news

Follow us

Site details